![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
*
Cancer Prevention Research Program and
Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109;
Department of Chemistry, University of Helsinki, Finland and
**
Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195
2To whom correspondence should be addressed at Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, MP-900, Seattle, WA 98109. E-mail: jlampe{at}fhcrc.org
The capacity to convert the soy isoflavone daidzein to equol in vivo is presumably determined by an individual’s intestinal microfloral populations; however, diet may also influence this conversion. The objectives of the present study were to determine whether a 1-mo supplementation of dietary fiber as wheat bran increases urinary equol excretion in equol excreters and stimulates equol production in nonexcreters and whether longer-term soy isoflavone intake increases equol production or alters overall urinary isoflavone excretion. First, we screened 74 women, ages 20–40 y, and determined their equol-excreter status. In these women, health and lifestyle patterns and habitual dietary intake did not differ according to equol-excreter status. Next, 26 of the women (13 equol excreters and 13 nonexcreters) were assigned (blocked on equol-excreter status) to either longer-term (1 mo) or short-term (4 d) soy protein supplementation. Within each soy treatment group, women participated in two 1-mo intervention periods (the exact length was determined by each woman’s menstrual cycle) during which they consumed their usual diets supplemented daily with either 0 or 16 g dietary fiber in a randomized crossover design. A 1-mo washout period separated the two diet periods. Among the 19 women who completed both periods, fiber supplementation did not increase equol production in equol excreters or nonexcreters. In addition, isoflavonoid excretion did not differ by fiber dose or length of soy intervention. These results suggest that a daily 16 g-fiber dose as wheat bran and the addition of soy protein do not alter significantly the capacity of colonic microflora to produce equol.
KEY WORDS: • isoflavones • lignans • equol • daidzein • soy • wheat bran • dietary fiber • humans
This article has been cited by other articles:
|
|
 |
|
  C. Atkinson, K. M Newton, E. J A. Bowles, M. Yong, and J. W Lampe Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States Am. J. Clinical Nutrition, March 1, 2008; 87(3): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brink, V. Coxam, S. Robins, K. Wahala, A. Cassidy, F. Branca, and on behalf of the PHYTOS Investigators Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study Am. J. Clinical Nutrition, March 1, 2008; 87(3): 761 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bolca, S. Possemiers, A. Herregat, I. Huybrechts, A. Heyerick, S. De Vriese, M. Verbruggen, H. Depypere, D. De Keukeleire, M. Bracke, et al. Microbial and Dietary Factors Are Associated with the Equol Producer Phenotype in Healthy Postmenopausal Women J. Nutr., October 1, 2007; 137(10): 2242 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Chang, J. Bigler, Y. Schwarz, S. S. Li, L. Li, I. B. King, J. D. Potter, and J. W. Lampe UGT1A1 Polymorphism Is Associated with Serum Bilirubin Concentrations in a Randomized, Controlled, Fruit and Vegetable Feeding Trial J. Nutr., April 1, 2007; 137(4): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell and S. J. Cole Method of Defining Equol-Producer Status and Its Frequency among Vegetarians J. Nutr., August 1, 2006; 136(8): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Song, C. Atkinson, C. L. Frankenfeld, T. Jokela, K. Wahala, W. K. Thomas, and J. W. Lampe Prevalence of Daidzein-Metabolizing Phenotypes Differs between Caucasian and Korean American Women and Girls J. Nutr., May 1, 2006; 136(5): 1347 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Decroos, E. Eeckhaut, S. Possemiers, and W. Verstraete Administration of Equol-Producing Bacteria Alters the Equol Production Status in the Simulator of the Gastrointestinal Microbial Ecosystem (SHIME) J. Nutr., April 1, 2006; 136(4): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L McVeigh, B. L Dillingham, J. W Lampe, and A. M Duncan Effect of soy protein varying in isoflavone content on serum lipids in healthy young men Am. J. Clinical Nutrition, February 1, 2006; 83(2): 244 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Hedlund, P. D. Maroni, P. G. Ferucci, R. Dayton, S. Barnes, K. Jones, R. Moore, L. G. Ogden, K. Wahala, H. M. Sackett, et al. Long-Term Dietary Habits Affect Soy Isoflavone Metabolism and Accumulation in Prostatic Fluid in Caucasian Men J. Nutr., June 1, 2005; 135(6): 1400 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Atkinson, C. L. Frankenfeld, and J. W. Lampe Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Dillingham, B. L. McVeigh, J. W. Lampe, and A. M. Duncan Soy Protein Isolates of Varying Isoflavone Content Exert Minor Effects on Serum Reproductive Hormones in Healthy Young Men J. Nutr., March 1, 2005; 135(3): 584 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Frankenfeld, C. Atkinson, W. K. Thomas, E. L. Goode, A. Gonzalez, T. Jokela, K. Wahala, S. M. Schwartz, S. S. Li, and J. W. Lampe Familial Correlations, Segregation Analysis, and Nongenetic Correlates of Soy Isoflavone-Metabolizing Phenotypes Experimental Biology and Medicine, October 1, 2004; 229(9): 902 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wiseman, K. Casey, E. A Bowey, R. Duffy, M. Davies, I. R Rowland, A. S Lloyd, A. Murray, R. Thompson, and D. B Clarke Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults Am. J. Clinical Nutrition, September 1, 2004; 80(3): 692 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer J. Nutr., August 1, 2004; 134(8): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kreijkamp-Kaspers, L. Kok, D. E. Grobbee, E. H. F. de Haan, A. Aleman, J. W. Lampe, and Y. T. van der Schouw Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial JAMA, July 7, 2004; 292(1): 65 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Newcomb, A. C. Bush, G. L. Stoner, J. W. Lampe, J. D. Potter, and J. Bigler No Evidence of an Association of JC Virus and Colon Neoplasia Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 662 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, S. Berman, O. Humbert, and J. W. Lampe In Vitro Incubation of Human Feces with Daidzein and Antibiotics Suggests Interindividual Differences in the Bacteria Responsible for Equol Production J. Nutr., March 1, 2004; 134(3): 596 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Frische, A. M. Hutchins, M. C. Martini, W. Thomas, and J. L. Slavin Effect of Flaxseed and Wheat Bran on Serum Hormones and Lignan Excretion in Premenopausal Women J. Am. Coll. Nutr., December 1, 2003; 22(6): 550 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Blair, S. E. Appt, A. A. Franke, and T. B. Clarkson Treatment with Antibiotics Reduces Plasma Equol Concentration in Cynomolgus Monkeys (Macaca fascicularis) J. Nutr., July 1, 2003; 133(7): 2262 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zubik and M. Meydani Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes J. Nutr., April 1, 2003; 133(4): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Blair, S. E. Appt, C. Bennetau-Pelissero, T. B. Clarkson, M. S. Anthony, V. Lamothe, and S. M. Potter Dietary Soy and Soy Isoflavones Have Gender-Specific Effects on Plasma Lipids and Isoflavones in Golden Syrian F1B Hybrid Hamsters J. Nutr., December 1, 2002; 132(12): 3585 - 3591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, H. E. Skor, E. D. Fitzgibbons, D. Scholes, C. Chen, K. Wahala, S. M. Schwartz, and J. W. Lampe Overnight Urinary Isoflavone Excretion in a Population of Women Living in the United States, and Its Relationship to Isoflavone Intake Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Messina, C. Gardner, and S. Barnes Gaining Insight into the Health Effects of Soy but a Long Way Still to Go: Commentary on the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease J. Nutr., March 1, 2002; 132(3): 547S - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF]
|
|
